Patient monitoring

accelerate imrt vmat planning

How it works
Masimo
rainbow SET™ technology

Philips patient monitoring with Masimo technology provides noninvasive, continuous hemoglobin monitoring you can rely on – at the point of care. Maintain consistent visibility on your patient's condition between invasive hemoglobin samples. Streamline workflows and drive down costs while providing clinically proven patient monitoring across care settings.

Masimo - continuous monitoring technology partner

Standard parameters

Masimo set pulse oximetry
Masimo SET™ pulse oximetry
pulse rate
Pulse rate
perfusion index
Perfusion Index

Optional parameters

Pleth variability index
Pleth Variability Index
Standard parameter
Total hemoglobin
Standard parameter
Methemoglobin saturation
Standard parameter
Carboxyhemoglobin
Standard parameter
Acoustic Respiration rate
Standard parameter
Oxygen content

Common measurement parameters

 

SpO2 - measure of oxygen saturation even through motion and low perfusion

 

SpHb1 - provides continuous visibility to changes – or lack of changes – in hemoglobin levels between invasive blood samples

 

PVi - measure of the dynamic changes in the Perfusion Index (PERF) that occur during one or more respiratory cycles

video thumbnail image

Philips IntelliVue and Masimo Horizon Trends

 

Horizon Trends are built into many Philips IntelliVue monitors and provide graphical representation of vital sign changes to make deviations easier to notice.

video thumbnail image

Masimo rainbow SET parameters

 

As part of the Philips / Masimo partnership, customers have access to Masimo’s noninvasive monitoring technologies in Philips IntelliVue monitors, including Masimo rainbow SET technology. The rainbow SET technology provides customers the option to purchase advance clinical measurement parameters.

*

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*

Final CEE consent

Intuitive display on Masimo measurements on Philips IntelliVue monitors


Clear and intuitive screen displays combine vital signs with Masimo rainbow SET parameters – providing trend data and current data on one easy-to-read screen.

Masimo rainbow SET parameters

Masimo rainbow SET parameters

 

SPO2 noninvasive oxygen saturation

SpHb noninvasive continuous hemoglobin

PVi Pleth Variability index

Pi PERF Perfusion index

SpOC noninvasive oxygen content

SpMet noninvasive methemoglobin

Masimo rainbow Horizon trends

Horizon trends

 

Horizon trends clearly indicate timely changes in patient condition – to aid you to quickly identify meaningful clinical deviations and take appropriate actions.

Noninvasive rainbow SET technology


Advanced rainbow SET sensors utilize multiple wavelengths of light to measure total hemoglobin (SpHb), Pleth Variability Index (PVi), oxygen content (SpOC). carboxyhemoglobin (SpCO) and methemoglobin (SpMet) noninvasively and continuously.
SET Technology

Works with your IT, works for your clinical teams

 

Philips IntelliVue monitoring platform fits securely into your hospital’s IT environment to capture timely patient data and feed it to the EMR. Capitalize on your IT investments, support your care teams with clinically proven solutions – without the need to purchase additional equipment.

 

With more than 1 million monitors sold since 2002, the IntelliVue family of monitoring solutions offers a proven track record for quality.

Noninvasive measurement technology – in clinical practice


Peer reviews have found that using SpHb® monitoring in conjunction with invasive blood sampling can deliver value in the ER, OR, and during transport.

References

 

Masimo clinical claims are referenced on this web page. All studies available at www.masimo.com/evidence/featured-studies/feature/

(1) SpHb** monitoring is not intended to replace lab testing. Blood samples should be analyzed by lab instruments prior to clinical decision making.

(2) Transt . 2014. 5:237.DOl:10.4172/2155-9864.1000237

(3) Awada WN et al J Clin Mon it Comput. DOI 10.1007/s10877-015-9660-4.

*Study Protocol: In each group, if researchers noted SpHb trended downward below 10 g/dl, a red blood cell transfusion was started and continued until SpHb trended upward above 10 g/dl. The transfusion threshold of 10 g/dl was predetermined by the study protocol and may not be appropriate for all patients. Blood sampling was the same for the control and test group. Artertal blood was drawn from a 20 gauge radial.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.